Locations:
Search IconSearch
November 24, 2025/Pediatrics/Cardiac Surgery

Ventricular Switch: What We’ve Learned From Our Growing Patient Cohort

Experts advise thorough assessment of right ventricle and reinforcement of tricuspid valve

Dr. Najm with colorful 3D-printed heart model

Ventricular switch is a surgical alternative to single-ventricular, Fontan physiology for select patients with complex congenital heart conditions. The novel operation is a combination of more common procedures that essentially switch the functions of the right and left ventricles. Ultimately, blood flows from the left ventricle to the pulmonary artery, and from the right ventricle to the aorta.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“For the past 20 years, many publications have touted the single-ventricular pathway and Fontan physiology as the simplest fix for some patients whose left ventricle cannot be routed to the aorta or adequately support systemic circulation,” says Hani Najm, MD, Chair of Pediatric and Adult Congenital Heart Surgery at Cleveland Clinic. “These patients usually do well for a decade or more. However, they eventually come to us with heart, liver, kidney and other organ failure. We now know that literally every Fontan — where you attach the venae cavae directly to the pulmonary artery, bypassing the heart — will fail at some point. Univentricular repair is not always the best solution for patients. Biventricular repair may be more complex initially, but the outcomes can be better, without inevitable multiorgan failure.”

Dr. Najm, who developed ventricular switch and performed the first procedure in 2016, published outcomes of his first five patients in 2021. Since then, Cleveland Clinic has continued refining the procedure. Now, Dr. Najm and colleagues have published results from a series of 17 patients (Eur J Cardiothorac Surg. 2025 Jul 1;67(7):ezaf155), updating outcomes and sharing what they’ve learned.

About the procedure

Ventricular switch, or right-ventricular-based biventricular conversion, can be used to treat patients with either a hypoplastic left ventricle (but sufficiently sized right ventricle) or anatomy that otherwise prevents systemic circulation from originating in the left ventricle (e.g., malpositioned aorta).

Advertisement

Several surgical techniques may be required to create biventricular circulation. Depending on the patient’s unique anatomy, techniques may include:

  • Septation of ventricles
  • Septation or repair of atrioventricular valve
  • Atrial switch/conversion
  • Superior vena cava translocation
  • Left ventricle to pulmonary artery conduit
  • Bidirectional cavopulmonary shunt if left ventricle is not adequate (1.5-ventricle configuration)

All techniques are not required for each patient.

As all ventricular switch procedures are personalized, 3D modeling is important for preoperative planning. MRI or CT is used to construct 3D replicas of each heart, with cardiac structures differentiated by color. The surgical team uses each 3D model to determine whether biventricular conversion is feasible and to define surgical steps in detail.

According to Dr. Najm, advanced imaging and 3D printing enable surgeries like ventricular switch, which once were considered too complex to attempt safely.

“Ventricular switch represents a paradigm shift in congenital surgery, offering a durable biventricular solution that may spare countless patients the progression to Fontan failure and the need for heart-liver transplantation,” says Edward Soltesz, MD, MPH, Surgical Director of Cleveland Clinic’s Kaufman Center for Heart Failure Treatment and Recovery. “The key is early identification of suitable candidates so they can realize the full long-term benefit of this transformative approach.”

Outcomes of 17 patients

In the retrospective study of the first 17 patients (median age 5.2 years, ranging from 4 months to 47 years) treated with ventricular switch at Cleveland Clinic between 2016 and 2023, five (30%) presented with stroke, multiorgan dysfunction or Fontan failure. Most of the patients had a history of complex heterotaxy. They had been selected for ventricular switch because left-ventricle-based biventricular circulation was not feasible.

Advertisement

Immediately after ventricular switch surgery in these patients:

  • Systemic oxygen saturation improved by a mean of 15 percentage points, from 79% to 94% (P = .008).
  • Elevated central venous pressure decreased by a mean of 13 mm Hg.
  • 94% (16 patients) had normal or only mildly dysfunctional subpulmonary ventricular function.
  • 76% (13 patients) had normal or only mildly dysfunctional subsystemic ventricular function.
  • All 11 patients who had atrioventricular valve repair maintained or improved valve function.

While three (18%) patients had in-hospital mortality — one due to ischemic stroke while on ECMO and two due to preexisting multiorgan failure — none (0%) had 30-day mortality. One-year survival was 79%. Five-year survival was 72%.

During a mean follow-up period of nearly 24 months, five (29%) of the patients had a reintervention, such as percutaneous valve replacement in the conduit or pulmonary artery banding.

One month or more after surgery, echocardiography showed sufficient subpulmonary ventricular function in all 14 patients and sufficient subsystemic ventricular function in 12 patients. All 14 patients had oxygen saturation higher than before surgery, with 12 having saturation greater than 90%.

Lessons learned

“Overall, ventricular switch has helped improve cyanosis, oxygen saturation, ventricular function and functional status (or exercise tolerance) in patients who conventionally may have been considered unsuitable for biventricular circulation,” says study coauthor Munir Ahmad, MD, a congenital heart surgeon at Cleveland Clinic. “Our midterm results have been generally favorable in patients with a range of cardiac anomalies, showing the broad utility of this procedure.”

Advertisement

Among the key lessons learned from these patients are:

1. The right ventricle must be assessed thoroughly before ventricular switch surgery.

“The short-term and long-term survival of these patients is dependent on the function of the right ventricle, which becomes the systemic ventricle,” says Dr. Ahmad. “Therefore, it is imperative to thoroughly assess right ventricular function preoperatively.”

Cleveland Clinic now evaluates patients during “switch boards,” gatherings of specialists similar to cancer center tumor boards. Heart surgeons, cardiologists and cardiac imaging specialists review a checklist of criteria for each patient being considered for ventricular switch.

“Switch boards help us assess criteria systematically,” Dr. Najm says. “Because ventricular switch and the congenital conditions addressed are so complex, we must ensure no detail is missed.”

Among the criteria for ideal ventricular switch candidates are:

  • Right ventricular end-diastolic pressure < 13 mm Hg
  • Right ventricular end-diastolic volume index > 50 ml/m2
  • Less-than-moderate arteriovenous valve regurgitation
  • Unobstructed pulmonary venous return
  • Normal liver and kidney function

A full list of considerations is available in the published study.

2. A well-repaired arteriovenous valve is fundamental to success. Annuloplasty is advised.

Sometimes, right ventricular function can fail after ventricular switch because of the tricuspid valve, which normally is not subject to systemic pressures.

“We have started preemptively performing annuloplasty for the tricuspid valve to ensure the valve will not dilate against high pressure and will not fail, causing failure of the ventricle,” Dr. Ahmad says.

3. Earlier intervention may lead to better outcomes.

Patients with univentricular physiology who present due to Fontan failure and subsequent multiorgan failure tend to have worse outcomes of ventricular switch than do patients who have the surgery sooner, note the surgeons.

Advertisement

“The outcomes are much better when we do ventricular switch before Fontan failure, and even instead of a Fontan procedure,” Dr. Najm says. “We recommend that patients are referred to us as soon as they show any sign of failure, assuming they have a left ventricle that was not previously rerouted. We will make an initial assessment and recommend appropriate candidates for full review by the switch board.”

Heart specialists should consider early conversion of any patient with Fontan physiology and two ventricles to biventricular circulation, he says. Even if left-ventricle-based conversion is selected instead of ventricular switch, do it before the patient has failure.

“I encourage congenital surgeons to learn the techniques for ventricular switch,” Dr. Najm adds. “Individually, the techniques are not complex. It is much better to provide this surgical treatment at the outset rather than as a reoperation later in a patient’s life, after another surgical treatment has failed.”

Related Articles

illustration of a heart operation
Novel Technique for Repairing Partial Anomalous Pulmonary Venous Return During Heart Transplant

Reproducible technique uses native recipient tissue, avoiding risks of complex baffles

Pulmonary valve
Not Just in TAVR: Hypoattenuating Leaflet Thickening Also Affects Patients After TPVR

HALT has unique clinical implications for adults with congenital heart disease

Dr. Najm in the operating room wearing surgical loupes
Cobrahead Reimplantation: Novel Technique for a Rare Congenital Abnormality

A reliable and reproducible alternative to conventional reimplantation and coronary unroofing

Dr. El Assaad listening to a young patient's heart
May 27, 2025/Pediatrics/Cardiology
Arrhythmia Burden in Congenitally Corrected Transposition of the Great Arteries

Retrospective study examines outcomes associated with common treatment pathways

Hands holding wearable sensor device
May 15, 2025/Pediatrics
Scoping Review Highlights Gaps in Wearable Sensor Studies

Experts raise concerns, make recommendations about improving the data

Dr. Amdani listens to young patient's heart
Entering the Modern Era of Pediatric VADs: What We’ve Learned So Far

Survival is improving, but the youngest patients still face disproportionate risk

surgical team during a heart operation
AATS Quality Gateway: Comprehensive and Nuanced Cardiac Surgery Risk Modeling Is at Hand

Launch of the tool promises to reshape quality assessment across the specialty

Mom doing skin to skin with newborn
March 5, 2025/Pediatrics/Cardiology
Facilitating Neuroprotective Care for Infants With Congenital Heart Disease

Program will support family-centered congenital heart disease care and staff educational opportunities

Ad